Coegin Pharma AB (NGM:COEGIN)
5.06
-0.02 (-0.39%)
At close: Dec 3, 2025
Coegin Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 7.37 | 19.68 | 5.55 | 3.82 | 25.66 | 16.65 |
| Cash & Short-Term Investments | 7.37 | 19.68 | 5.55 | 3.82 | 25.66 | 16.65 |
| Cash Growth | - | 254.70% | 45.39% | -85.13% | 54.12% | - |
| Other Receivables | 0.32 | 1.15 | 0.64 | 3.13 | 4.64 | 2.5 |
| Receivables | 0.32 | 1.15 | 0.64 | 3.13 | 4.64 | 2.5 |
| Prepaid Expenses | 0.2 | 0.01 | 0.02 | 0.02 | 0.03 | - |
| Other Current Assets | 1.89 | -0 | - | - | - | - |
| Total Current Assets | 9.78 | 20.84 | 6.21 | 6.97 | 30.33 | 19.14 |
| Property, Plant & Equipment | 0.15 | 0.15 | 0.3 | 0.49 | 0 | 0 |
| Other Intangible Assets | 3.9 | 6.05 | 8.92 | 11.79 | - | - |
| Other Long-Term Assets | - | - | - | 10 | - | - |
| Total Assets | 13.89 | 27.04 | 15.43 | 29.25 | 30.34 | 19.15 |
| Accounts Payable | 0.49 | 0.98 | 1.79 | 2 | 9.73 | 1.77 |
| Accrued Expenses | 1.51 | 0.66 | 2.66 | 1.71 | 0.22 | - |
| Current Income Taxes Payable | - | - | - | 0.18 | - | - |
| Other Current Liabilities | 0.25 | 0.15 | 4.24 | 4.34 | 0.31 | 0.66 |
| Total Current Liabilities | 2.24 | 1.78 | 8.68 | 8.23 | 10.26 | 2.43 |
| Total Liabilities | 2.24 | 1.78 | 8.68 | 8.23 | 10.26 | 2.43 |
| Common Stock | 12.44 | 12.44 | 4.7 | 35.33 | 27.57 | 23.11 |
| Additional Paid-In Capital | 136.18 | 136.2 | 101.6 | 94.76 | 66.38 | 41.5 |
| Retained Earnings | - | - | - | - | -75.07 | -47.93 |
| Comprehensive Income & Other | -136.98 | -123.38 | -99.54 | -109.08 | 1.2 | 0.04 |
| Shareholders' Equity | 11.65 | 25.26 | 6.75 | 21.01 | 20.07 | 16.71 |
| Total Liabilities & Equity | 13.89 | 27.04 | 15.43 | 29.25 | 30.34 | 19.15 |
| Net Cash (Debt) | 7.37 | 19.68 | 5.55 | 3.82 | 25.66 | 16.65 |
| Net Cash Growth | - | 254.70% | 45.39% | -85.13% | 54.12% | - |
| Net Cash Per Share | 0.28 | 1.04 | 0.60 | 0.56 | 4.32 | 12.74 |
| Filing Date Shares Outstanding | 24.88 | 24.88 | 9.39 | 6.94 | 6.94 | 1.31 |
| Total Common Shares Outstanding | 24.88 | 24.88 | 9.39 | 6.94 | 6.94 | 1.31 |
| Working Capital | 7.54 | 19.06 | -2.47 | -1.26 | 20.07 | 16.71 |
| Book Value Per Share | 0.47 | 1.02 | 0.72 | 3.03 | 2.89 | 12.79 |
| Tangible Book Value | 7.75 | 19.21 | -2.17 | 9.22 | 20.07 | 16.71 |
| Tangible Book Value Per Share | 0.31 | 0.77 | -0.23 | 1.33 | 2.89 | 12.79 |
| Machinery | - | 0.63 | 0.64 | 0.68 | 0.15 | 0.15 |
Source: S&P Capital IQ. Standard template. Financial Sources.